Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Glioma has been considered to be the most frequent primary tumor within the central nervous system (CNS). The complexity of glioma, especially the existence of the blood-brain barrier (BBB), makes the survival and prognosis of glioma remain poor even after a standard treatment based on surgery, radi...
Main Authors: | Shanshan Wang, Ying Meng, Chengyi Li, Min Qian, Rongqin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-12-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-4991/6/1/3 |
Similar Items
-
Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
by: Huilong Luo, et al.
Published: (2020-11-01) -
A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system
by: Lu Y, et al.
Published: (2018-10-01) -
Characterization of Cationic Bolaamphiphile Vesicles for siRNA Delivery into Tumors and Brain
by: Taejin Kim, et al.
Published: (2020-06-01) -
ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas
by: David Gomez-Zepeda, et al.
Published: (2019-12-01) -
Progress and perspectives on targeting nanoparticles for brain drug delivery
by: Huile Gao
Published: (2016-07-01)